Looking back at genomic medicine in 2011

Genome Medicine

Volumn 4, Issue 1, 2012, Pages

  Auffray, Charles ^a   Caulfield, Timothy ^b   Khoury, Muin J ^c   Lupski, James R ^d,e   Schwab, Matthias ^f,g   Veenstra, Timothy ^h  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAMAZEPINE; HLA B15 ANTIGEN; MESSENGER RNA; PROTEOME; STABLE ISOTOPE; THIOURIDINE;

BIOETHICS; BIOINFORMATICS; BIPOLAR DISORDER; BONE CANCER; CLINICAL PRACTICE; CONSUMER; DISASTER; DISEASE PREDISPOSITION; DNA REPLICATION; DRESS SYNDROME; EDITORIAL; ENZYME METABOLISM; FUTUROLOGY; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GERMLINE MICRONUCLEUS; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; HYPERSENSITIVITY REACTION; LIVER INJURY; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; META ANALYSIS (TOPIC); METAGENOMICS; MICROBIOME; MORTALITY; MOUTH CAVITY; NOSE IRRITATION; PHARMACOGENOMICS; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SKIN; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TRIGEMINUS NEURALGIA; UROGENITAL SYSTEM;

EID: 84867544196     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm308     Document Type: Editorial

References (41)

1. Mills RE, Walter K, Stewart C, Handsaker RE, Chen K, Alkan C, Abyzov A, Yoon SC, Ye K, Cheetham RK, Chinwalla A, Conrad DF, Fu Y, Grubert F, Hajirasouliha I, Hormozdiari F, Iakoucheva LM, Iqbal Z, Kang S, Kidd JM, Konkel MK, Korn J, Khurana E, Kural D, Lam HY, Leng J, Li R, Li Y, Lin CY, Luo R, et al. Mapping copy number variation by population-scale genome sequencing. Nature 2011, 470:59-65. 10.1038/nature09708, 3077050, 21293372.
2. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40. 10.1016/j.cell.2010.11.055, 3065307, 21215367.
3. Liu P, Erez A, Nagamani SC, Dhar SU, Kołodziejska KE, Dharmadhikari AV, Cooper ML, Wiszniewska J, Zhang F, Withers MA, Bacino CA, Campos-Acevedo LD, Delgado MR, Freedenberg D, Garnica A, Grebe TA, Hernández-Almaguer D, Immken L, Lalani SR, McLean SD, Northrup H, Scaglia F, Strathearn L, Trapane P, Kang SH, Patel A, Cheung SW, Hastings PJ, Stankiewicz P, Lupski JR, et al. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 2011, 146:889-903. 10.1016/j.cell.2011.07.042, 21925314.
4. Liu P, Erez A, Nagamani SC, Bi W, Carvalho CM, Simmons AD, Wiszniewska J, Fang P, Eng PA, Cooper ML, Sutton VR, Roeder ER, Bodensteiner JB, Delgado MR, Prakash SK, Belmont JW, Stankiewicz P, Berg JS, Shinawi M, Patel A, Cheung SW, Lupski JR. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet 2011, 20:1975-1988. 10.1093/hmg/ddr078, 21355048.
5. Carvalho CM, Ramocki MB, Pehlivan D, Franco LM, Gonzaga-Jauregui C, Fang P, McCall A, Pivnick EK, Hines-Dowell S, Seaver LH, Friehling L, Lee S, Smith R, Del Gaudio D, Withers M, Liu P, Cheung SW, Belmont JW, Zoghbi HY, Hastings PJ, Lupski JR. Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome. Nat Genet 2011, 43:1074-1081. 10.1038/ng.944, 21964572.
6. Gonzaga-Jauregui C, Lupski JR, Gibb RA. Human genome sequencing in health and disease. Annu Rev Med 2012, 63:35-61. 10.1146/annurev-med-051010-162644, 22248320.
7. Lupski JR, Belmont JW, Boerwinkle E, Gibbs RA. Clan genomics and the complex architecture of human disease. Cell 2011, 147:32-43. 10.1016/j.cell.2011.09.008, 21962505.
8. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342. 10.1038/nature10098, 21593866.
9. Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A, Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R. The quantitative proteome of a human cell. Mol Syst Biol 2011, 7:549-556. 3261713, 22068332.
10. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst 2009, 5:1512-1526.
11. Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett 2009, 583:3966-3973. 10.1016/j.febslet.2009.10.036, 19850042.
12. Lame ME, Chambers EE, Blatnik M. Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry. Anal Biochem 2011, 419:133-913. 10.1016/j.ab.2011.08.010, 21888888.
13. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180. 10.1038/nature09944, 21508958.
14. MetaHit Consortium. , http://www.metahit.eu/
15. Lewis CM J, Obregon-Tito A, Tito RY, Foster MW, Spicer PG. The Human Microbiome Project: lessons from human genomics. Trends Microbiol 2012, 20:1-4. 10.1016/j.tim.2011.10.004, 22112388.
16. Human Microbiome Project. , http://commonfund.nih.gov/Hmp/
17. Solovyev VV, Tatarinova TV. Towards the integration of genomics, epidemiological and clinical data. Genome Med 2011, 3:48. 10.1186/gm264, 21867574.
18. Kinross JM, Darzi AW, Jeremy K Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med 2011, 3:14. 10.1186/gm228, 21392406.
19. Schwab M, Schaeffeler E. Warfarin pharmacogenetics meets clinical use. Blood 2011, 118:2938-2939. 10.1182/blood-2011-07-367763, 21921056.
20. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004, 428:486. 10.1038/428486a, 15057820.
21. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011, 364:1126-1133. 10.1056/NEJMoa1009717, 21428768.
22. Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011, 20:1034-1041. 10.1093/hmg/ddq537, 21149285.
23. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O'Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011, 364:1134-1143. 10.1056/NEJMoa1013297, 3113609, 21428769.
24. Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe'er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011, 141:338-347. 10.1053/j.gastro.2011.04.001, 21570397.
25. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60. 10.1038/nature10354, 21886157.
26. Green ED, Guyer MS. Charting a course for genomic medicine: from base pairs to bedside. Nature 2011, 470:204-213. 10.1038/nature09764, 21307933.
27. Khoury MJ, Gwinn M, Bowen MS, Dotson WD. Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health 2011, doi: 10.2105/AJPH.2011.300299.
28. Schully SS, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational research in cancer genetics: the road less travelled. Publ Health Genomics 2011, 14:1-8.
29. Gwinn M, Grossniklaus DA, Yu W, Melillo S, Wulf A, Flome J, Dotson WD, Khoury MJ. Horizon scanning for new genomic tests. Genet Med 2011, 13:161-165. 10.1097/GIM.0b013e3182011661, 21233720.
30. Food and Drug Administration: Table of pharmacogenomic biomarkers in drug labels. , http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm
31. Manolio TA, Green ED. Genomics reaches the clinic: from basic discoveries to clinical impact. Cell 2011, 147:14-16. 10.1016/j.cell.2011.09.012, 21962499.
32. Berg J, Khoury MJ, Evans JP. Deploying whole genome sequence in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011, 13:499-504. 10.1097/GIM.0b013e318220aaba, 21558861.
33. Caulfield T, McGuire A. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu Rev Med 2012, 63:23-33. 10.1146/annurev-med-062110-123753, 21888511.
34. Wright CF, Gregory-Jones S. Size of the direct-to-consumer genomic testing market. Genet Med 2010, 12:594. 10.1097/GIM.0b013e3181ead743, 20697288.
35. Wright C. Ban on DTC genetic tests in Germany. Population Health Genome Foundation 2009, http://www.phgfoundation.org/news/4562/
36. American Bar Association Resolution 114. ABA urges direct access to diagnostic medical testing. 2011, American Bar Association., http://www.abanow.org/2011/07/2011am114/
37. Murray ABV, Carson MJ, Morris CA, Beckwith J. Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer: misrepresenting science in the genetic-testing marketplace. Trends Genet 2010, 26:459-461. 10.1016/j.tig.2010.08.001, 20828856.
38. Su Y, Howard HC, Borry P. Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. Community Genet 2011, 2:135-146.
39. Einsiedel EF, Geransar R. Framing genetic risk: trust and credibility markers in online direct-to-consumer advertising for genetic testing. New Genet Soc 2009, 28:339-362.
40. Kuehn BM. Inconsistent results, inaccurate claims plague direct-to-consumer gene tests. JAMA 2010, 304:1313-1315. 10.1001/jama.2010.1328, 20858870.
41. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genome wide profiling to assess disease risk. N Engl J Med 2011, 364:524-534. 10.1056/NEJMoa1011893, 21226570.